Get the app!
Back to Trades
Total Value
$19.6K
Net $19.6K bought
Filing Date
Nov 20, 2026
1 transaction
Purchases
$19.6K
1 transaction

Trade Summary

On Nov 19, 2026, Bancroft Robert E., President and CEO, Director, purchased $19.6K of AEON Biopharma, Inc. (AEON) across 1 transaction. The filing covers Class A Common Stock and reflects net buying of $19.6K. Reported prices ranged from $0.13. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
AEON
CIK
0001837607

Insider Information

Role
President and CEO, Director
Location
ALISO VIEJO, CA

Filing Details

Filing Date
Nov 20, 2026
Transaction Date
Nov 19, 2026
Accession Number
0002066370-26-000002
Form Type
4
Net Trading Amount
$19.6K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Nov 19, 2026Class A Common Stock152,333$0.13Purchase$19.6K

Want live alerts when Bancroft Robert E. trades again?

Download Insider Trades to track AEON, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1213 to $0.1345 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC Filing